Aclaris Therapeutics (ACRS) Non Operating Income (2015 - 2026)
Aclaris Therapeutics' Non Operating Income came in at $2.73 million for Q2 2026, down 8.3% from $2.98 million a year earlier but up 15.4% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Non Operating Income (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Non Operating Income of $10.58 million, down 11.8% year-over-year; for FY2025, it was $11.45 million, up 16.1% from FY2024.
- Going back by year, Non Operating Income was $9.87 million in FY2024 (+16.0%) and $8.51 million in FY2023.
- The five-year range for quarterly Non Operating Income is $1.87 million (Q2 2024) to $3.12 million (Q4 2024).
- Year-over-year, Non Operating Income has declined for four consecutive quarters, with growth averaging 16.3% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q2 2025 (growth of 59.5%), and the weakest in Q1 2026 (a decline of 21.0%).
- Business Quant data shows ACRS's Non Operating Income at $2.37 million (Q1 2026), $2.94 million (Q4 2025) and $2.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn | 2.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Sep 30, 2016 | 118,000.00 |
| Jun 30, 2016 | 118,000.00 |
| Mar 31, 2016 | 100,000.00 |
| Sep 30, 2015 | 8,000.00 |
| Jun 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 6,000.00 |
API Access
Aclaris Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();